Ulberto Pharma Private Limited
About Ulberto Pharma Private Limited
Data last updated:
Ulberto Pharma Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24110MP2019PTC048507.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Anu Mehra and Yash Mehra Mohan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 504 Block B – 3 Paras Hermitage Hoshangabad Road, Bhopal, Madhya Pradesh, India – 462026.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.5 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹61.09 Lakh (net margin 40.9%) and EBITDA of ₹84.77 Lakh (EBITDA margin 56.7%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 31% over five years.
Company details
Contact details
Ulberto Pharma Private Limited's registered office is in Bhopal, Madhya Pradesh.
- Registered AddressFlat No. 504 Block B – 3 Paras Hermitage Hoshangabad Road, Bhopal, Madhya Pradesh, India – 462026
- IndustryChemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ulberto Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ulberto Pharma Private Limited, buy the company report.
Financials of Ulberto Pharma Private Limited
FY 2025 filings availableUlberto Pharma Private Limited reported revenue of ₹1.5 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 14% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹84.77 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹61.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 56.7% | ||||
| Net Profit Margin | 40.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ulberto Pharma Private Limited, buy the company report.
Board of directors of Ulberto Pharma Private Limited
Ulberto Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anu Mehra | Director | 02 May 2019 | 7 Years 6 Months | Current |
| Yash Mehra Mohan Also directs: Yashved Remedies Private Limited, Indimonk Remedies Private Limited, Uvan Pharmaceuticals Private Limited and 1 more | Director | 02 May 2019 | 7 Years 6 Months | Current |
Peer comparison
Ulberto Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Danavendra Builders Private Limited | ₹1.5 Cr (FY 2024) | 67.0% | Kolkata, West Bengal, India | |||
| NVS Metal Foundation | ₹1.5 Cr (FY 2025) | 56.0% | Moradabad, Uttar Pradesh, India | |||
| Plastopol Polymers Private Limited | ₹1.5 Cr (FY 2023) | 15.0% | Perintalmanna, Kerala, India | |||
| Small Rock (OPC) Private Limited | ₹1.5 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Mettalhunk Private Limited | ₹1.5 Cr (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Ulberto Pharma Private Limitedthis company | ₹1.5 Cr (FY 2025) | ₹61.09 Lakh | 40.9% | 14.0% | Bhopal, Madhya Pradesh, India | |
| Forefront Enterprises Private Limited | ₹1.5 Cr (FY 2024) | 26.0% | Thrikkakkara, Kerala, India | |||
| Delicacy Impex India Private Limited | ₹1.49 Cr (FY 2021) | Srinagar, Jammu and Kashmir, India | ||||
| Nagorao Auto Engineering Works Private Limited | ₹1.49 Cr (FY 2024) | 30.0% | Raipur, Chhattisgarh, India | |||
| Prenad Trading Private Limited | ₹1.49 Cr (FY 2019) | 1106.0% | Noida, Uttar Pradesh, India | |||
| Sevens Sharps Lifts and Escalators Private Limited | ₹1.49 Cr (FY 2021) | 5.0% | Peroorkada, Kerala, India |
To see the full peer comparison of Ulberto Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ulberto Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ulberto Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ulberto Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ulberto Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Dilip Moghe ceased to be Director on 01 Apr 2021.
Frequently asked questions
Ulberto Pharma is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 May 2019 (7+ years old) and is registered under CIN U24110MP2019PTC048507.
Ulberto Pharma has 2 current directors:
- Anu Mehra - Director
- Yash Mehra Mohan - Director
The latest financial statements of Ulberto Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Ulberto Pharma is U24110MP2019PTC048507. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ulberto Pharma was incorporated on 02 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ulberto Pharma by revenue are Danavendra Builders Private Limited, NVS Metal Foundation, Plastopol Polymers Private Limited, Small Rock (OPC) Private Limited, Mettalhunk Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Dilip Moghe ceased to be Director on 01 Apr 2021. Anu Mehra was appointed as Director on 02 May 2019. Yash Mehra Mohan was appointed as Director on 02 May 2019.
The registered office of Ulberto Pharma is at Flat No. 504 Block B – 3 Paras Hermitage Hoshangabad Road, Bhopal, Madhya Pradesh, India – 462026.
Ulberto Pharma operates in the chemicals industry, in the manufacturing segment.
Ulberto Pharma can be reached at its registered office: Flat No. 504 Block B – 3 Paras Hermitage Hoshangabad Road, Bhopal, Madhya Pradesh, India – 462026.
Ulberto Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
